Matches in SemOpenAlex for { <https://semopenalex.org/work/W4318710386> ?p ?o ?g. }
- W4318710386 endingPage "172" @default.
- W4318710386 startingPage "157" @default.
- W4318710386 abstract "Breast cancer (BC) is the most common heterogeneous disease in women and one of the leading causes of cancer-related death. Surgery, chemotherapy, radiotherapy, hormone, and targeted therapy are the gold standards for BC treatment. One of the significant challenges during the treatment of BC represents resistance to chemotherapeutics, resistance that severely limits the use and effectiveness of the drugs used for BC treatment. Therefore, it is essential to develop new strategies to improve therapeutic efficacy. Circular RNAs (circRNAs) are a large group of non-coding RNAs that covalently form closed circular loops by joining their 5′, and 3′; ends. Accumulating evidence suggests that circRNAs have a vital role in cancer development, progression, and BC resistance to chemotherapy. The purpose of this review is to discuss the biological properties of circRNAs, and how circRNAs induce resistance to conventional therapeutic anti-cancer drugs used in BC treatment, by emphasizing and summarizing the potential roles of circRNAs in mechanisms of drug resistance, such as drug efflux, apoptosis dysfunction, autophagy, and DNA damage repair. CircRNAs are associated with drug resistance via ATP-binding cassette (ABC) efflux transporters, while some others by inhibition of cell apoptosis, thus leading to resistance to tamoxifen in BC cells. In contrast, others are involved in the promotion of BC cells chemoresistance by doxorubicininduced autophagy. CircRNAs may have clinical significance in regulating or overcoming BC drug resistance and may give directions towards a novel approach to personalized BC treatment. CircRNAs may significantly contribute to the identification of new therapeutic targets for the prevention of BC chemoresistance." @default.
- W4318710386 created "2023-02-01" @default.
- W4318710386 creator A5002815367 @default.
- W4318710386 creator A5005917856 @default.
- W4318710386 creator A5007267686 @default.
- W4318710386 creator A5021350727 @default.
- W4318710386 creator A5035296343 @default.
- W4318710386 creator A5044141800 @default.
- W4318710386 date "2022-01-01" @default.
- W4318710386 modified "2023-10-18" @default.
- W4318710386 title "circRNAs in drug resistance of breast cancer" @default.
- W4318710386 cites W1523439243 @default.
- W4318710386 cites W1846631206 @default.
- W4318710386 cites W1965568527 @default.
- W4318710386 cites W1965727556 @default.
- W4318710386 cites W1966411071 @default.
- W4318710386 cites W1966557314 @default.
- W4318710386 cites W1968480103 @default.
- W4318710386 cites W1984789674 @default.
- W4318710386 cites W1985339653 @default.
- W4318710386 cites W1997952119 @default.
- W4318710386 cites W1999653222 @default.
- W4318710386 cites W2005734249 @default.
- W4318710386 cites W2005852730 @default.
- W4318710386 cites W2012345757 @default.
- W4318710386 cites W2014184691 @default.
- W4318710386 cites W2020769043 @default.
- W4318710386 cites W2025346084 @default.
- W4318710386 cites W2033673127 @default.
- W4318710386 cites W2036430139 @default.
- W4318710386 cites W2041762805 @default.
- W4318710386 cites W2047172303 @default.
- W4318710386 cites W2066242940 @default.
- W4318710386 cites W2083642975 @default.
- W4318710386 cites W2083907066 @default.
- W4318710386 cites W2096745115 @default.
- W4318710386 cites W2100751052 @default.
- W4318710386 cites W2102099949 @default.
- W4318710386 cites W2108376231 @default.
- W4318710386 cites W2122970222 @default.
- W4318710386 cites W2125120607 @default.
- W4318710386 cites W2130392703 @default.
- W4318710386 cites W2131308508 @default.
- W4318710386 cites W2135103035 @default.
- W4318710386 cites W2141414987 @default.
- W4318710386 cites W2150322923 @default.
- W4318710386 cites W2152719653 @default.
- W4318710386 cites W2156701124 @default.
- W4318710386 cites W2164778107 @default.
- W4318710386 cites W2169052701 @default.
- W4318710386 cites W2174049160 @default.
- W4318710386 cites W2219781244 @default.
- W4318710386 cites W2485244285 @default.
- W4318710386 cites W2559471688 @default.
- W4318710386 cites W2568368705 @default.
- W4318710386 cites W2606001457 @default.
- W4318710386 cites W2737712434 @default.
- W4318710386 cites W2747105326 @default.
- W4318710386 cites W2796241264 @default.
- W4318710386 cites W2803209940 @default.
- W4318710386 cites W2803631610 @default.
- W4318710386 cites W2806486243 @default.
- W4318710386 cites W2807407703 @default.
- W4318710386 cites W2807508331 @default.
- W4318710386 cites W2810062789 @default.
- W4318710386 cites W2811512821 @default.
- W4318710386 cites W2883797857 @default.
- W4318710386 cites W2892938674 @default.
- W4318710386 cites W2893761792 @default.
- W4318710386 cites W2897972067 @default.
- W4318710386 cites W2901068426 @default.
- W4318710386 cites W2904089587 @default.
- W4318710386 cites W2919278937 @default.
- W4318710386 cites W2924280631 @default.
- W4318710386 cites W2944809178 @default.
- W4318710386 cites W2945838677 @default.
- W4318710386 cites W2946122221 @default.
- W4318710386 cites W2954183884 @default.
- W4318710386 cites W2963653570 @default.
- W4318710386 cites W2968060972 @default.
- W4318710386 cites W2968993120 @default.
- W4318710386 cites W2993326585 @default.
- W4318710386 cites W2993848932 @default.
- W4318710386 cites W2996672362 @default.
- W4318710386 cites W2998701262 @default.
- W4318710386 cites W3007300208 @default.
- W4318710386 cites W3009747115 @default.
- W4318710386 cites W3013867138 @default.
- W4318710386 cites W3018218719 @default.
- W4318710386 cites W3021429039 @default.
- W4318710386 cites W3026927470 @default.
- W4318710386 cites W3027669624 @default.
- W4318710386 cites W3034269777 @default.
- W4318710386 cites W3047567828 @default.
- W4318710386 cites W3049064987 @default.
- W4318710386 cites W3080715228 @default.
- W4318710386 cites W3085572122 @default.
- W4318710386 cites W3088672891 @default.